Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Cassidy James. Director active across 2 companies, notably SpringWorks Therapeutics, Inc.. In total, 9 reports have been recorded. History available since 1 September 2023. The latest transaction was disclosed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Cassidy James is a declarant associated with SpringWorks Therapeutics, Inc. and holds the role of Chief Medical Officer there. He has 9 filings in total, and the sampled recent filings cover the period from 2023-01-09 to 2025-07-02, with buy and sell amounts shown as EUR 0.